Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02307279
What this trial is testing

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Who this might be right for
OverweightObesity
Gelesis, Inc. 436
Early research (Phase 1)Study completedNCT02148861
What this trial is testing

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesType 2 Diabetes Mellitus
Novo Nordisk A/S 49
Post-approval studies (Phase 4)Study completedNCT01519674
What this trial is testing

Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 582
Large-scale testing (Phase 3)Looking for participantsNCT04786262
What this trial is testing

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated 57
Early research (Phase 1)Study completedNCT01497561
What this trial is testing

Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 15
Large-scale testing (Phase 3)Study completedNCT00432276
What this trial is testing

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 803
Testing effectiveness (Phase 2)Study completedNCT01079325
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 170
Large-scale testing (Phase 3)Study completedNCT02856113
What this trial is testing

Phase 3 Alogliptin Pediatric Study

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 152
Large-scale testing (Phase 3)Study completedNCT00614120
What this trial is testing

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 929
Early research (Phase 1)Study completedNCT01037582
What this trial is testing

A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 155
Large-scale testing (Phase 3)Study completedNCT00978627
What this trial is testing

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 548
Testing effectiveness (Phase 2)Study completedNCT03848793
What this trial is testing

Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Who this might be right for
Diabetes Mellitus, Type 2
Jiangsu HengRui Medicine Co., Ltd. 128
Large-scale testing (Phase 3)Study completedNCT01106625
What this trial is testing

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 469
Testing effectiveness (Phase 2)Study completedNCT01447147
What this trial is testing

Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes Mellitus
Amgen 332
Early research (Phase 1)Study completedNCT05374343
What this trial is testing

The Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT01647308
What this trial is testing

Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Ionis Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01018017
What this trial is testing

A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT02292433
What this trial is testing

Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 12
Not applicableLooking for participantsNCT07743021
What this trial is testing

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

Who this might be right for
Non-communicable Diseases (NCD)NeoplamsCancer+11 more
Center for Molecular Fingerprinting Research Nonprofit LLC 15,000
Not applicableStudy completedNCT01548235
What this trial is testing

Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 423
Next Page